Antibody Discovery News and Research

RSS
New design strategy marks a potential advance in the fight against Alzheimer's disease

New design strategy marks a potential advance in the fight against Alzheimer's disease

Human immune repertoire may not commonly produce cross-neutralizing antibodies to coronaviruses

Human immune repertoire may not commonly produce cross-neutralizing antibodies to coronaviruses

Twist Bioscience Identifies Competitive Antibodies for SARS-CoV-2

Twist Bioscience Identifies Competitive Antibodies for SARS-CoV-2

OXGENE™ reports third consecutive year of 100% year on year revenue growth

OXGENE™ reports third consecutive year of 100% year on year revenue growth

Israeli scientists discover monoclonal antibody that neutralizes SARS-CoV-2

Israeli scientists discover monoclonal antibody that neutralizes SARS-CoV-2

Scientists are developing synthetic COVID-19 antibody to treat sick patients

Scientists are developing synthetic COVID-19 antibody to treat sick patients

Accelerating Antibody Discovery with Next-Generation Single-Cell Analysis

Accelerating Antibody Discovery with Next-Generation Single-Cell Analysis

Berkeley Lights Announces GEPAD to Attack COVID-19 and Other Viruses

Berkeley Lights Announces GEPAD to Attack COVID-19 and Other Viruses

Celltrion announces key milestones in its efforts to fight COVID-19

Celltrion announces key milestones in its efforts to fight COVID-19

DSI alumni use computational design to quickly discover treatments for COVID-19

DSI alumni use computational design to quickly discover treatments for COVID-19

Berkeley Lights Launches Cell Line Development 2.0 Workflow to Find Top Clones for Complex Antibody Therapeutics

Berkeley Lights Launches Cell Line Development 2.0 Workflow to Find Top Clones for Complex Antibody Therapeutics

Turbine appoints new SAB members to guide its simulation-first drug discovery mission

Turbine appoints new SAB members to guide its simulation-first drug discovery mission

Integral Molecular announces panel of P2X7 antibodies for autoimmune disorders

Integral Molecular announces panel of P2X7 antibodies for autoimmune disorders

IONTAS, Adaptate Biotherapeutics join forces to generate and optimize antibodies for novel cancer targets

IONTAS, Adaptate Biotherapeutics join forces to generate and optimize antibodies for novel cancer targets

Streamlining Immuno-Oncological Therapeutic Antibody Discovery

Streamlining Immuno-Oncological Therapeutic Antibody Discovery

Sphere Fluidics and Peak Analysis and Automation introduce integrated micro-plate handling and single cell analysis capabilities

Sphere Fluidics and Peak Analysis and Automation introduce integrated micro-plate handling and single cell analysis capabilities

We are excited to release our latest software update with new Cyto-Mine functionalities!

We are excited to release our latest software update with new Cyto-Mine functionalities!

BioStreamline: Streamlining the development of next generation biotherapeutics

BioStreamline: Streamlining the development of next generation biotherapeutics

Sphere Fluidics closes $2 million USD (c. £1.5 million GBP) investment round

Sphere Fluidics closes $2 million USD (c. £1.5 million GBP) investment round

Sphere Fluidics collaborates with Peak Analysis and Automation to increase throughput in antibody discovery and cell line development

Sphere Fluidics collaborates with Peak Analysis and Automation to increase throughput in antibody discovery and cell line development